Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 07 - 29 tags : Cancer save search
CytRx Highlights Preliminary Results of Cohort C of QUILT 88, a Phase 2 Pancreatic Cancer Trial That Includes Aldoxorubicin, Expected to be Released in Q1 2022
Published: 2021-07-29 (Crawled : 20:00) - biospace.com/
IBRX | $4.815 -12.3% -14.02% 7.9M
|
Manufacturing
|
| O: 0.61%
H: 1.47%
C: -3.12%
phase 2 results cancer trial pancreatic pancreas
Women Cancer Victims Opposed to Johnson & Johnson's 'Texas Two-Step' Bankruptcy Ploy Urge Passage of Reforms Introduced by Warren, Durbin, Nadler, Blumenthal, and Maloney
Published: 2021-07-29 (Crawled : 15:15) - prnewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.33%
H: 0.35%
C: -0.32%
women cancer
Everest Medicines Receives Pediatric and Rare Severe Disease Priority Review Designation from Taiwan FDA for Sacituzumab Govitecan-Hziy in Metastatic Triple-Negative Breast Cancer
Published: 2021-07-29 (Crawled : 11:00) - prnewswire.com
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: 0.27%
H: 0.21%
C: -0.6%
disease fda cancer breast cancer designation rare
Energy Fuels Announces Strategic Alliance with RadTran, LLC for the Recovery of Isotopes Needed for Emerging Cancer Therapeutics
Published: 2021-07-29 (Crawled : 10:00) - prnewswire.com
UUUU | $5.36 2.29% 1.31% 3.1M
|
Non-Energy Minerals
|
| O: 2.2%
H: 1.08%
C: -2.33%
energy cancer
Cancer Biopsy Market Size To Reach $44.51 Billion By 2027 | CAGR: 11.13%: Grand View Research, Inc.
Published: 2021-07-29 (Crawled : 09:00) - prnewswire.com
QGEN | $41.52 -0.88% 0.0% 820K
|
Health Technology
|
| O: 0.85%
H: 0.75%
C: 0.31%
BDX | $233.83 -0.23% 3.49% 780K
|
Health Technology
|
| O: 0.52%
H: 0.51%
C: 0.2%
QGEN | $41.52 -0.88% 0.0% 820K
|
Health Technology
|
| O: 0.85%
H: 0.75%
C: 0.31%
NTRA | News M | $91.47 0.47% 0.47% 810K
|
Health Services
|
| O: -0.14%
H: 4.0%
C: 1.22%
ILMN | $122.74 -1.38% -1.4% 1.2M
|
Health Technology
|
| O: 1.06%
H: 0.0%
C: -1.17%
HOLX | $76.71 -0.62% -0.63% 910K
|
Health Technology
|
| O: 1.28%
H: 4.7%
C: 1.12%
EXAS | $63.24 -0.46% -0.46% 1.2M
|
Health Technology
|
| O: -7.38%
H: 6.81%
C: 4.1%
BIOC | $0.4349 -10.32% 750K
|
Health Services
|
| O: -0.24%
H: 0.37%
C: -6.24%
cancer research
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.